Wagner, 1987 - Google Patents
Scientific highlights:“slices of life”Wagner, 1987
View PDF- Document ID
- 4637842461450016026
- Author
- Wagner H
- Publication year
- Publication venue
- Journal of Nuclear Medicine
External Links
Snippet
The 34th Annual Meeting of The Soci ety of Nuclear Medicine (SNM), held last June in Toronto, Canada,/narked the 10th anniversary of the Scientific Meeting Highlights given by Henry N. Wagner, Jr., MD. During this closing session, which has become a Society …
- 238000009206 nuclear medicine 0 abstract description 23
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Carlin et al. | A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers | |
Sasaki et al. | Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver | |
JP5998171B2 (en) | Method for detecting heart failure | |
Werner et al. | The changing face of nuclear cardiology: guiding cardiovascular care toward molecular medicine | |
Werner et al. | Recent paradigm shifts in molecular cardiac imaging—Establishing precision cardiology through novel 18F-labeled PET radiotracers | |
Mastrocola et al. | Update of the Brazilian guideline on nuclear cardiology-2020 | |
Schomäcker et al. | Use of myocardial imaging agents for tumour diagnosis–a success story? | |
Burman et al. | Management of patients with thyroid carcinoma: application of thallium-201 scintigraphy and magnetic resonance imaging | |
Pelletier-Galarneau et al. | Molecular imaging of cardiac amyloidosis | |
Naito et al. | Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan | |
Manrique et al. | Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy | |
Kalinin et al. | The parathyroid glands: imaging and surgery | |
Wagner | Scientific highlights:“slices of life” | |
EP2882863B1 (en) | System and method for quantitative mapping of mitocondrial complex 1 | |
Emren et al. | Evaluation of Trastuzumab-induced early cardiac dysfunction using two-dimensional Strain Echocardiography. | |
Wagner | Oncology: a new engine for PET/SPECT | |
Qin et al. | Noninvasive diagnosis of hereditary transthyretin-related cardiac amyloidosis: A case report | |
Minamihaba et al. | Pulsed Doppler tissue imaging for the assessment of myocardial viability: comparison with 99mTc sestamibi perfusion imaging | |
RU2800818C1 (en) | Method of breast cancer diagnostics with her2/neu hyperexpression | |
Horblitt | Amyloid Imaging | |
Liu et al. | 111 In—antimyosin antibody imaging for detection of myocardial infarction: a quantitative approach | |
Neumann et al. | Imaging in parathyroid diseases | |
Giordano et al. | Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy | |
Chaaban et al. | The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis | |
Lee et al. | Global and Regional Variations in Transthyretin Cardiac Amyloidosis: A Comparison of Longitudinal Strain and 99mTechnetium Pyrophosphate Imaging |